Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03927781 · ClinicalTrials.gov registry record · Phase 3
Perioperative Pregabalin in Ureteroscopy: a Pilot
A Phase 3 study, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- Phase 3
- Development phase
- 10
- Enrollment target
NCT03927781: Completed Phase 3 study, sponsored by University of Missouri-Columbia.
NCT03927781 is a Phase 3 study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 10 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03927781, a Phase 3 study, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 10 participants
- Enrollment target
Study Summary
The investigators propose a pilot clinical trial on the use of perioperative pregabalin in order to decrease ureteral stent related symptoms and decrease opioid usage after ureteroscopy with stent placement. Patients undergoing ureteroscopy with stent placement will receive a single dose of 300 mg pregabalin PO in the preoperative area. This work will assess safety and feasibility of studying this regimen at our institution, with the aim of performing a randomized, placebo-controlled, double-blinded study in the future.
Interventions
- DRUG Pregabalin 300mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2020-10-17 |
| Phase | Phase 3 |
What the finished NCT03927781 record still lists
NCT03927781 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Pregabalin 300mg is the first listed.
NCT03927781 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03927781 about?
NCT03927781 is a clinical study titled "Perioperative Pregabalin in Ureteroscopy: a Pilot". The investigators propose a pilot clinical trial on the use of perioperative pregabalin in order to decrease ureteral stent related symptoms and decrease opioid usage after ureteroscopy with stent placement. Patients undergoing ureteroscopy with stent placement will receive a single dose of 300 mg p...
What is the current status of trial NCT03927781?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 10 participants. The study started on 2019-04-01. Estimated completion is 2020-10-17.
What interventions are being tested in trial NCT03927781?
The interventions under investigation include: Pregabalin 300mg (DRUG).
Who is sponsoring clinical trial NCT03927781?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03927781's enrollment target sits among peer trials
10 1989th of 2000 higher than 9 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI